B.J. Stish - Concepedia

Author

B.J. Stish

University of Minnesota

Also Known As

B J Stish, B. Stish, B.J. Stish, Brad J Stish, Brad J. Stish, Brad Stish

Publications

272

Citations

H-Index

Concepts

All Affiliations

University of Minnesota University of Minnesota Medical Center Twin Cities Orthopedics Masonic Cancer Center NHS Blood and Transplant

About

B.J. Stish is an author at University of Minnesota specializing in immunology, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	36
2	Cell Biology	1	1	36
3	Immunology	1	1	36
4	Neuro-oncology	1	1	36
5	Tumor Biology	1	1	36

B.J. Stish

Publications

223

Citations

H-Index

Page 1

	Year	Citations
Increasing Anticarcinoma Activity of an Anti-erbB2 Recombinant Immunotoxin by the Addition of an Anti-EpCAM sFv B.J. Stish, Hua Chen, Yanqun Shu, Clinical Cancer Research	2007	44
A Novel Reduced Immunogenicity Bispecific Targeted Toxin Simultaneously Recognizing Human Epidermal Growth Factor and Interleukin-4 Receptors in a Mouse Model of Metastatic Breast Carcinoma Seunguk Oh, B.J. Stish, Deepali Sachdev, Clinical Cancer Research	2009	39
Anti-glioblastoma effect of a recombinant bispecific cytotoxin cotargeting human IL-13 and EGF receptors in a mouse xenograft model B.J. Stish, Seunguk Oh, Daniel A. Vallera Journal of Neuro-Oncology Mouse Xenograft ModelNeuro-oncologyGliomaImmunologyEgf Receptors	2007	36
A Bispecific Recombinant Cytotoxin (DTEGF13) Targeting Human Interleukin-13 and Epidermal Growth Factor Receptors in a Mouse Xenograft Model of Prostate Cancer B.J. Stish, Hua Chen, Yanqun Shu, Clinical Cancer Research	2007	34
Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activity B.J. Stish, S Oh, H Chen, British Journal of Cancer	2009	33
Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model D. A. Vallera, B.J. Stish, Yongqian Shu, Gut	2008	25
A New Drug Delivery Method of Bispecific Ligand-Directed Toxins, Which Reduces Toxicity and Promotes Efficacy in a Model of Orthotopic Pancreatic Cancer S Oh, B.J. Stish, Selwyn M. Vickers, Pancreas	2010	12

Page 1